Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Sunday, February 1, 2004 - 07:00, By: ALSN Staff
Study of new compound open
The international pharmaceutical company Novartis has opened a large-scale, dose-finding trial of a compound called TCH346 for treatment of ALS.